Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6280037 | Neuroscience Letters | 2016 | 6 Pages |
Abstract
Using positron emission tomography (PET), the present study assessed the binding of [11C]flumazenil to GABA-A receptors in anesthetized rats following a single intravenous injection of an active dose of either etifoxine (25Â mg/kg) or diazepam (1Â mg/kg), which are both anxiolytic drugs. [11C]flumazenil binding was measured in five discrete brain structures, namely the caudate putamen, hippocampus, cerebellum, occipital cortex and parietal cortex. As expected, diazepam injection produced a significant decrease in [11C]flumazenil binding, which was interpreted as benzodiazepine GABA-A receptor occupancy, whereas etifoxine increased the binding of [11C]flumazenil. This first use of in vivo imaging after etifoxine administration revealed the activated binding pattern of [11C]flumazenil and highlighted the pharmacological differences between etifoxine and benzodiazepines. Using the same [11C]flumazenil radiotracer, PET neuroimaging could be applied to larger animals and, ultimately, to human subjects, thus providing new perspectives for better defining the molecular pharmacology of etifoxine.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Caroline Bouillot, Frédéric Bonnefoi, François Liger, Luc Zimmer,